Birdwatch Note
2023-02-14 16:29:56 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The unvaccinated patient was denied the heart transplant because if she contracted COVID-19 after the transplant, it “…could result in death and the loss of the transplanted organ”. Transplant patients are on immunosuppressants, making them more likely to contract COVID-19. https://www.ucsfhealth.org/education/faq-covid-19-basics-for-transplant-and-other-immunosuppressed-patients
Written by AAA837933C5A1F132183372A1D1374EB8D0959D9E665314AE3D2901B5C526DA1
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1625323708033413120
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1625532806334906376
- noteId - 1625532806334906376
- participantId - AAA837933C5A1F132183372A1D1374EB8D0959D9E665314AE3D2901B5C526DA1
- noteAuthorParticipantId -
- createdAtMillis - 1676392196626
- tweetId - 1625323708033413120
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The unvaccinated patient was denied the heart transplant because if she contracted COVID-19 after the transplant, it “…could result in death and the loss of the transplanted organ”. Transplant patients are on immunosuppressants, making them more likely to contract COVID-19. https://www.ucsfhealth.org/education/faq-covid-19-basics-for-transplant-and-other-immunosuppressed-patients
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-02-14 16:29:56 UTC (1676392196626) |
1969-12-31 23:59:59 UTC (-1) |
2023-03-07 02:11:29 UTC (1678155089929) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-02-14 22:16:59 -0600 | 026BFC2CA42CE2B27983687E28DEF90E6D4B691888D0D642488A4A0C2E6E4D8D | Rating Details |
| 2023-02-14 11:49:22 -0600 | 08956573BB2DC88E23E98EE7F3B4E96E8DD83B6A4D0EBCA73CA0D23CA67550C1 | Rating Details |
| 2023-02-14 13:32:04 -0600 | 0DD001197221FEB3CAAC92286DDB07C2483989F311A8B5F1689F19FA1D60E578 | Rating Details |
| 2023-02-14 19:34:00 -0600 | 11BD4779EEDEF6AD0A8B9909631A879F67A440041395BBCD87190183433B5876 | Rating Details |
| 2023-02-14 14:23:33 -0600 | 1336446E52147E5398266C3CB3FCB8413DA3543F8852EB9FACA1B561C812C9E5 | Rating Details |
| 2023-02-14 16:31:34 -0600 | 13CFEBB121BCDB4F34A72B049594DDE1184A31F965F4BB82E5492600140A1E1E | Rating Details |
| 2023-02-15 21:06:22 -0600 | 1670A8C8C855006F5D9C2B997D63DF56991262F681B3B012965036F082D0C4AE | Rating Details |
| 2023-02-14 19:12:53 -0600 | 192471D0346DEAA64C6F7B1455A31A85037821D15687B1EBB53FD01DC35E0550 | Rating Details |
| 2023-02-14 13:19:22 -0600 | 1B8859FE458603781A31ECE05920D925E1218E97096B9493F6ACA00CC36FCB5B | Rating Details |
| 2023-02-14 15:36:38 -0600 | 20C196A7DB5117BD64F7FDA5F6093C8454E847EB0F83F677947B4CF53FBF3A2C | Rating Details |
| 2023-02-14 12:49:51 -0600 | 21BE9B32C4E2B15F7A0915C247F2FD5259A5EC6A893FE12E47FF4C7559FAED9B | Rating Details |
| 2023-02-14 13:48:19 -0600 | 2741BDA1810F54E6EC3A8AC6A9A7B80F995437124EB307358199D5799F75BC15 | Rating Details |
| 2023-02-14 18:20:07 -0600 | 2745D24359F86B9DF70E0BF51EF58153CB3E1922CAA1D7AAA2DAC7503173682C | Rating Details |
| 2023-02-14 16:08:38 -0600 | 3027F5934C8DD804461F35860165D244ADE554D290A9CDC7BAE01884D5B5E635 | Rating Details |
| 2023-02-14 20:18:01 -0600 | 314F63A886DAFCB3B3ECF910EBA3BBDAC60D52230BB00702426F697F29ECB489 | Rating Details |
| 2023-02-14 13:15:53 -0600 | 35B0D7251CCEBD26C3F331E60BD744B470920DDE219B67E228EECBCA87B2410B | Rating Details |
| 2023-02-14 12:17:18 -0600 | 367B64B0864E7CC8288B1EEAF62A434DC48D9A7D4E8C5364450AC5BE42DA0EEE | Rating Details |
| 2023-02-14 14:25:24 -0600 | 3EAC4A44063FCE0D50461130509B78D825FCF2A730DDAC082300CD232EFAE33E | Rating Details |
| 2023-02-16 23:57:09 -0600 | 4710C636981973B659D6CE609449FD661FD22EA7536B6911628E16EA7E8CEDB6 | Rating Details |
| 2023-02-14 14:22:08 -0600 | 5965F1D70DF83F7E70E83939B59ED0CDCDE40CEBD28927BC611BC3763BE5D80D | Rating Details |
| 2023-02-14 16:59:12 -0600 | 5EDC2B8BBEA2C25FBA40E8849AF6DD751A4AE52F674E4E2311C09F82909AD4F8 | Rating Details |
| 2023-02-14 14:25:46 -0600 | 66E65E029587E0660CB3BCDC294F69822E9AB36998D880C702CD1B4414D20A3F | Rating Details |
| 2023-02-15 06:27:03 -0600 | 6BE237C0A508809C3F2FE2E38DE6158FC210DD760DAED11B986F98AF4997E9D5 | Rating Details |
| 2023-02-14 19:19:09 -0600 | 7175491E2937771DC8E2EFA0666903A9402CC00A9E13206B61B170AD2F7C5CF5 | Rating Details |
| 2023-02-14 11:41:51 -0600 | 71EB268E7A8F69DFC819CAAE0A760DFD1B895A145E18F142043E0C9900DB4061 | Rating Details |
| 2023-02-14 19:19:18 -0600 | 72D5F27E7A772B26AA3649E7F2400C401E88D836A30C1B47D6A381B5D1C27D1D | Rating Details |
| 2023-02-14 19:10:22 -0600 | 7B1F4C67C03FCAD80C1B49450FB70E169702904CD94A3A95909A9CE394FA9F35 | Rating Details |
| 2023-02-14 10:47:37 -0600 | 803CEE394E0F3E70D4176A8A2D86F197E68B4CD82367AF3F816B5669B0545937 | Rating Details |
| 2023-02-14 13:16:48 -0600 | 862E84AD6C488AB3037EAC4682346692F09F61D556BF80E01E4F8B21C28D08CA | Rating Details |
| 2023-02-14 19:59:14 -0600 | 8B1D4F3858C934B2B6D2D486B058B4300ABEBFACD940C1FFB0FCB851CE3C2544 | Rating Details |
| 2023-03-04 08:39:02 -0600 | 99295592472187BD8F763072008A651EA48A48188B7217A990DDF3F6858A09F2 | Rating Details |
| 2023-02-15 00:56:42 -0600 | 99A04DBEE564ECFE86E3460BF91DAB57A3565292D63504E942EAC2F1417B1B67 | Rating Details |
| 2023-02-14 16:26:18 -0600 | 9A996C20258339F1E763B3261E42E299AD781AB439BB9766E186570C3CB1523A | Rating Details |
| 2023-02-14 12:59:02 -0600 | 9F296ECF02FC98633E36F82F80461FEDC0CBB40B16766C62D09F200079D84F3D | Rating Details |
| 2023-02-14 15:32:21 -0600 | A88FB00CDE8F5FE4A3D2FABE6F6507EB10B076C8A10905D0EF33624B6A47F124 | Rating Details |
| 2023-02-14 10:54:33 -0600 | AD1BC936B6390FB9262BE31EE3528F887F49A55E1C78D22A233BF724FC25AEC6 | Rating Details |
| 2023-02-14 12:18:56 -0600 | B1BD4BB05166B3C8C5875BCAFF3DBC66D5D35D9C446BBA83DE144812CA4552FE | Rating Details |
| 2023-02-14 11:18:58 -0600 | B28F4CE045E58D53A3207DB373E580FE27ACF6E6F4EF018D88B2C87BCA2C6E94 | Rating Details |
| 2023-02-14 20:11:55 -0600 | B2BB4B31F4141D895AEEBB60EC7D7DEF47225E6FF7069991A11C8EAF67418647 | Rating Details |
| 2023-02-14 16:54:32 -0600 | B4034C78831384EF5129F31116A45A33887F8C60AF99FF23092086781089FEFB | Rating Details |
| 2023-02-16 11:06:32 -0600 | B50A116C786E706BA346AC5D89C78EDCAB93E7533BBFF34F058BA4E1C2BC8B41 | Rating Details |
| 2023-02-14 11:08:07 -0600 | B7A920201E850F5AB3E1F429619DA6D0F87A1D1295D14A676712A2061B36F894 | Rating Details |
| 2023-02-14 18:58:10 -0600 | B9A9382D9039D0A1D4EF6385C72450F92C6E52A1B4D5AF9A7C20E0465A939DFB | Rating Details |
| 2023-02-14 11:14:39 -0600 | C0DEE1D3AD41EC68684A356B0CEF8126C0BA3B35559E39DEF3D9E270EF43AEF4 | Rating Details |
| 2023-02-14 11:35:53 -0600 | C378931E048482D2BFDF00DC95644D6377CBCB812C79FF87D77B5E48595B3DA3 | Rating Details |
| 2023-02-14 20:14:21 -0600 | CDC4958C567505C0396B7CAA67ACB92C9BF024369C25FD15D45AC2699CA3840C | Rating Details |
| 2023-02-14 16:19:55 -0600 | D368E97E30CBF4EF68647D85A67FD2854E94B392AD3F8EDD6DA7083D2A916E9A | Rating Details |
| 2023-02-14 15:52:32 -0600 | EE30048906CC71004ACC4937A10DE1A64290FD597FEED7B0A349DBBE795685C6 | Rating Details |
| 2023-02-14 17:56:13 -0600 | EE99B2E4151B7129E0B6410282C2393FE2A107301A6DD5B81F5B32C837C60EDC | Rating Details |
| 2023-02-14 12:07:49 -0600 | EF8FF2725BD1CF155598EC971F4F9AE7C250F3E1015461063E64B6C674DBBB9E | Rating Details |
| 2023-02-14 16:35:02 -0600 | EFFBD8205C0CC45D66F694A0086A4B1AB751CBBFE4AA0148C89334EB44343CB3 | Rating Details |
| 2023-02-15 03:52:39 -0600 | F13DE5F0BC6747304C6E2FB90C0258FABD5AD5021950FF5CB2DC73C174764E5E | Rating Details |
| 2023-02-14 13:16:22 -0600 | F687D5DE8A079E1AFDB5F8D22C428EBA97ED5D71B92589A91A85677DA009270C | Rating Details |
| 2023-02-14 18:02:33 -0600 | F8B6CEA94641CE9077BE8EAC6A4243DD4F0F09AAAA2099E067782D5287AC21B8 | Rating Details |
| 2023-02-14 11:50:15 -0600 | FFCC0A2F8DA177BFEBE0EDE7EB902CAFB60386BF1FEDE7432B6C820AF35C87DF | Rating Details |
| 2023-04-02 00:17:05 -0500 | Rating Details | |
| 2023-02-14 14:04:18 -0600 | Rating Details | |
| 2023-02-14 16:19:55 -0600 | Rating Details | |
| 2023-02-14 16:31:34 -0600 | Rating Details | |
| 2023-02-14 15:36:38 -0600 | Rating Details | |
| 2023-04-02 00:17:05 -0500 | Rating Details | |
| 2023-02-14 18:20:07 -0600 | Rating Details | |
| 2023-02-14 13:16:22 -0600 | Rating Details | |
| 2023-02-14 11:14:39 -0600 | Rating Details | |
| 2023-02-14 19:10:22 -0600 | Rating Details | |
| 2023-02-14 12:59:02 -0600 | Rating Details | |
| 2023-02-14 14:22:08 -0600 | Rating Details | |
| 2023-02-14 20:11:55 -0600 | Rating Details | |
| 2023-02-14 20:18:01 -0600 | Rating Details | |
| 2023-02-14 11:35:53 -0600 | Rating Details | |
| 2023-02-14 19:59:14 -0600 | Rating Details | |
| 2023-02-14 11:49:22 -0600 | Rating Details | |
| 2023-02-14 12:18:56 -0600 | Rating Details | |
| 2023-03-04 08:39:02 -0600 | Rating Details | |
| 2023-02-14 19:19:09 -0600 | Rating Details | |
| 2023-02-14 22:16:59 -0600 | Rating Details | |
| 2023-02-16 23:57:09 -0600 | Rating Details | |
| 2023-02-14 15:52:32 -0600 | Rating Details | |
| 2023-02-15 06:27:03 -0600 | Rating Details | |
| 2023-02-14 13:32:04 -0600 | Rating Details | |
| 2023-02-14 10:47:37 -0600 | Rating Details | |
| 2023-02-14 16:54:32 -0600 | Rating Details | |
| 2023-02-14 11:08:07 -0600 | Rating Details | |
| 2023-02-14 13:48:19 -0600 | Rating Details | |
| 2023-02-14 14:04:18 -0600 | Rating Details | |
| 2023-02-15 21:06:22 -0600 | Rating Details | |
| 2023-02-14 13:16:48 -0600 | Rating Details | |
| 2023-02-14 18:02:33 -0600 | Rating Details | |
| 2023-02-15 03:52:39 -0600 | Rating Details | |
| 2023-02-14 13:19:22 -0600 | Rating Details | |
| 2023-02-14 19:12:53 -0600 | Rating Details | |
| 2023-02-14 18:58:10 -0600 | Rating Details | |
| 2023-02-14 12:07:49 -0600 | Rating Details | |
| 2023-02-14 12:17:18 -0600 | Rating Details | |
| 2023-02-14 10:54:33 -0600 | Rating Details | |
| 2023-02-14 16:08:38 -0600 | Rating Details | |
| 2023-02-15 00:56:42 -0600 | Rating Details | |
| 2023-02-14 11:18:58 -0600 | Rating Details | |
| 2023-02-14 14:25:24 -0600 | Rating Details | |
| 2023-02-14 16:35:02 -0600 | Rating Details | |
| 2023-02-14 20:14:21 -0600 | Rating Details | |
| 2023-02-14 16:59:12 -0600 | Rating Details | |
| 2023-02-14 19:34:00 -0600 | Rating Details | |
| 2023-02-14 14:23:33 -0600 | Rating Details | |
| 2023-02-14 13:15:53 -0600 | Rating Details | |
| 2023-02-14 15:32:21 -0600 | Rating Details | |
| 2023-02-14 11:50:15 -0600 | Rating Details | |
| 2023-02-14 17:56:13 -0600 | Rating Details | |
| 2023-02-14 16:26:18 -0600 | Rating Details | |
| 2023-02-14 14:25:46 -0600 | Rating Details | |
| 2023-02-16 11:06:32 -0600 | Rating Details | |
| 2023-02-14 19:19:18 -0600 | Rating Details | |
| 2023-02-14 12:49:51 -0600 | Rating Details |